Skip to main content
Erschienen in: Current Cardiology Reports 3/2014

01.03.2014 | Nuclear Cardiology (V Dilsizian, Section Editor)

The Potential of FDG PET/CT for Early Diagnosis of Cardiac Device and Prosthetic Valve Infection Before Morphologic Damages Ensue

verfasst von: Wengen Chen, Jongho Kim, Olga P. Molchanova-Cook, Vasken Dilsizian

Erschienen in: Current Cardiology Reports | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Diagnosis of cardiac mechanical device or prosthesis valve infection, and more importantly accurate localization of the infection site, such as defibrillator pocket, pacemaker lead, annular or peri-annular valve ring abscesses remain clinically challenging. Inconclusive diagnosis can lead to delayed antibiotic therapy, device extraction or surgical intervention, which may have dire consequences to the patient. Among patients with suspected cardiac mechanical device or prosthetic valve infection, recent publications advocate the use of 18 F-fluoro-2-deoxyglucose positron emission tomography computed tomography (FDG PET/CT), particularly when anatomy based imaging studies, such as echocardiography or CT, are uncertain or negative. A potential advantage of FDG PET/CT is in its detection of inflammatory cells early in the infection process, before morphologic damages ensue. However, there are many unanswered questions in the literature. There is a need for standardization amongst the various imaging studies, such as dietary preparation, duration and timing of image acquisition, image processing with and without CT attenuation correction, and more importantly image interpretation criteria. The answer for these issues awaits well designed, prospective studies.
Literatur
1.
Zurück zum Zitat Basu S, Zhuang H, Torigian DA, et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124–45.PubMedCrossRef Basu S, Zhuang H, Torigian DA, et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124–45.PubMedCrossRef
2.
Zurück zum Zitat Brinker J. Imaging for infected cardiac implantable electronic devices: a new trick for your pet. J Am Coll Cardiol. 2012;59:1626–8.PubMedCrossRef Brinker J. Imaging for infected cardiac implantable electronic devices: a new trick for your pet. J Am Coll Cardiol. 2012;59:1626–8.PubMedCrossRef
3.
Zurück zum Zitat Bertagna F, Bisleri G, Motta F, et al. Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging. 2012;28:1417–25.PubMedCrossRef Bertagna F, Bisleri G, Motta F, et al. Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging. 2012;28:1417–25.PubMedCrossRef
4.
Zurück zum Zitat Dilsizian V, Bacharach SL, Beanlands SR, et al. ASNC Imaging Guidelines for Nuclear Cardiology Procedures: PET Myocardial Perfusion and Metabolism Clinical Imaging J Nucl Cardiol. 2009;16:651, ISSN 1532–6551 (Online) doi:10.1007/s12350-009-9094-9. Dilsizian V, Bacharach SL, Beanlands SR, et al. ASNC Imaging Guidelines for Nuclear Cardiology Procedures: PET Myocardial Perfusion and Metabolism Clinical Imaging J Nucl Cardiol. 2009;16:651, ISSN 1532–6551 (Online) doi:10.​1007/​s12350-009-9094-9.
5.
Zurück zum Zitat Dilsizian V, Taillefer R. Journey in Evolution of Nuclear Cardiology: Will There Be Another Quantum Leap with the F-18 labeled Myocardial Perfusion Tracers? J Am Coll Cardiol Imaging. 2012;5:1269–84.CrossRef Dilsizian V, Taillefer R. Journey in Evolution of Nuclear Cardiology: Will There Be Another Quantum Leap with the F-18 labeled Myocardial Perfusion Tracers? J Am Coll Cardiol Imaging. 2012;5:1269–84.CrossRef
6.
Zurück zum Zitat Chen W, Dilsizian V. Fluorodeoxyglucose PET Imaging of Coronary Atherosclerosis and Plaque Inflammation. Curr Cardiol Rep. 2010;12:179–84.PubMedCrossRef Chen W, Dilsizian V. Fluorodeoxyglucose PET Imaging of Coronary Atherosclerosis and Plaque Inflammation. Curr Cardiol Rep. 2010;12:179–84.PubMedCrossRef
7.
Zurück zum Zitat Chen W, Dilsizian V. Targeted PET/CT Imaging of Vulnerable Atherosclerotic Plaques: Microcalcification with Sodium Fluoride and Inflammation with Fluorodeoxyglucose. Curr Cardiol Rep. 2013;15:364–9.PubMedCrossRef Chen W, Dilsizian V. Targeted PET/CT Imaging of Vulnerable Atherosclerotic Plaques: Microcalcification with Sodium Fluoride and Inflammation with Fluorodeoxyglucose. Curr Cardiol Rep. 2013;15:364–9.PubMedCrossRef
8.
Zurück zum Zitat Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011;34:1013–27.PubMedCrossRef Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011;34:1013–27.PubMedCrossRef
9.
Zurück zum Zitat Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33:705–11.PubMedCrossRef Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33:705–11.PubMedCrossRef
10.
Zurück zum Zitat Chu VH, Crosslin DR, Friedman JY, et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med. 2005;118(1416):e19–24. Chu VH, Crosslin DR, Friedman JY, et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med. 2005;118(1416):e19–24.
11.
Zurück zum Zitat Tarakji KG, Chan EJ, Cantillon DJ, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010;7:1043–7.PubMedCrossRef Tarakji KG, Chan EJ, Cantillon DJ, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010;7:1043–7.PubMedCrossRef
12.
Zurück zum Zitat Pill SG, Parvizi J, Tang PH, et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty. 2006;21:91–7.PubMedCrossRef Pill SG, Parvizi J, Tang PH, et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty. 2006;21:91–7.PubMedCrossRef
13.•
Zurück zum Zitat Bensimhon L, Lavergne T, Hugonnet F, et al. Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect. 2011;17:836–44. The study prospectively evaluated the usefulness of FDG PET/CT for the diagnosis of device infection in 21 patients with clinically suspected device infection, and 14 controls free of infection. Compared to the gold standard of device culture after extraction or clinical follow-up, FDG PET/CT showed a high sensitivity and specificity for diagnosis of device infection, superior for pocket infection than lead infection evaluation.PubMedCrossRef Bensimhon L, Lavergne T, Hugonnet F, et al. Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect. 2011;17:836–44. The study prospectively evaluated the usefulness of FDG PET/CT for the diagnosis of device infection in 21 patients with clinically suspected device infection, and 14 controls free of infection. Compared to the gold standard of device culture after extraction or clinical follow-up, FDG PET/CT showed a high sensitivity and specificity for diagnosis of device infection, superior for pocket infection than lead infection evaluation.PubMedCrossRef
14.•
Zurück zum Zitat Ploux S, Riviere A, Amraoui S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8:1478–81. The study showed the potential value of FDG-PET/CT scanning in the diagnosis of pacing lead endocarditis in 10 difficult cases with absence of valvular or lead vegetations on transthoracic and transesophageal echocardiography. FDG PET/CT showed lead infection in 6 cases which were confirmed on subsequent culture of lead after extraction. In the 4 cases with a negative FDG PET/CT scan, the pacing system was left in place without objective signs of active lead endocarditis during follow-up. The study showed that FDG PET/CT may guide the clinical decision making for difficult cases with clinically suspected cardiac device infection.PubMedCrossRef Ploux S, Riviere A, Amraoui S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8:1478–81. The study showed the potential value of FDG-PET/CT scanning in the diagnosis of pacing lead endocarditis in 10 difficult cases with absence of valvular or lead vegetations on transthoracic and transesophageal echocardiography. FDG PET/CT showed lead infection in 6 cases which were confirmed on subsequent culture of lead after extraction. In the 4 cases with a negative FDG PET/CT scan, the pacing system was left in place without objective signs of active lead endocarditis during follow-up. The study showed that FDG PET/CT may guide the clinical decision making for difficult cases with clinically suspected cardiac device infection.PubMedCrossRef
15.••
Zurück zum Zitat Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616–25. The study first showed that FDG PET/CT can differentiate device infection from recent post-implant inflammation changes. FDG PET/CT findings can guide clinical management of infected cases by localizing the infection sites of superficial or deep pocket infection.PubMedCrossRef Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616–25. The study first showed that FDG PET/CT can differentiate device infection from recent post-implant inflammation changes. FDG PET/CT findings can guide clinical management of infected cases by localizing the infection sites of superficial or deep pocket infection.PubMedCrossRef
16.
Zurück zum Zitat Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.PubMedCrossRef Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.PubMedCrossRef
17.
Zurück zum Zitat Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200–9.PubMedCrossRef Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200–9.PubMedCrossRef
18.
Zurück zum Zitat Hill EE, Herijgers P, Claus P, et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J. 2007;154:923–8.PubMedCrossRef Hill EE, Herijgers P, Claus P, et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J. 2007;154:923–8.PubMedCrossRef
19.
Zurück zum Zitat Mathew J, Anand A, Addai T, et al. Value of echocardiographic findings in predicting cardiovascular complications in infective endocarditis. Angiology. 2001;52:801–9.PubMedCrossRef Mathew J, Anand A, Addai T, et al. Value of echocardiographic findings in predicting cardiovascular complications in infective endocarditis. Angiology. 2001;52:801–9.PubMedCrossRef
20.
Zurück zum Zitat Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33:2023–9.PubMedCrossRef Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33:2023–9.PubMedCrossRef
21.
Zurück zum Zitat Habib G, Hoen B, Tornos P, et al. ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.PubMedCrossRef Habib G, Hoen B, Tornos P, et al. ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.PubMedCrossRef
22.
Zurück zum Zitat Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.PubMedCrossRef Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.PubMedCrossRef
23.
Zurück zum Zitat Erba PA, Conti U, Lazzeri E, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med. 2012;53:1235–43.PubMedCrossRef Erba PA, Conti U, Lazzeri E, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med. 2012;53:1235–43.PubMedCrossRef
24.••
Zurück zum Zitat Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18 F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374–82. The study prospectively studied 72 consecutive patients suspected of having prosthesis valve endocarditis. The results showed that FDG PET/CT can detect prosthesis valve infection earlier than the echocardiography with a high sensitivity and specificity. Inclusion of abnormal FDG uptake at the site of the prosthetic valve, as a novel major criterion, can significantly increase the sensitivity of the modified Duke criteria, without compromising specificity.PubMedCrossRef Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18 F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374–82. The study prospectively studied 72 consecutive patients suspected of having prosthesis valve endocarditis. The results showed that FDG PET/CT can detect prosthesis valve infection earlier than the echocardiography with a high sensitivity and specificity. Inclusion of abnormal FDG uptake at the site of the prosthetic valve, as a novel major criterion, can significantly increase the sensitivity of the modified Duke criteria, without compromising specificity.PubMedCrossRef
25.
Zurück zum Zitat Saby L, Le Dolley Y, Laas O, et al. Early diagnosis of abscess in aortic bioprosthetic valve by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography. Circulation. 2012;126:e217–20.PubMedCrossRef Saby L, Le Dolley Y, Laas O, et al. Early diagnosis of abscess in aortic bioprosthetic valve by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography. Circulation. 2012;126:e217–20.PubMedCrossRef
26.
Zurück zum Zitat Schouten LR, Verberne HJ, Bouma BJ, et al. Surgical glue for repair of the aortic root as a possible explanation for increased F-18 FDG uptake. J Nucl Cardiol. 2008;15:146–7.PubMedCrossRef Schouten LR, Verberne HJ, Bouma BJ, et al. Surgical glue for repair of the aortic root as a possible explanation for increased F-18 FDG uptake. J Nucl Cardiol. 2008;15:146–7.PubMedCrossRef
27.
Zurück zum Zitat Fagman E, Perrotta S, Bech-Hanssen O, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol. 2012;22:2407–14.PubMedCrossRef Fagman E, Perrotta S, Bech-Hanssen O, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol. 2012;22:2407–14.PubMedCrossRef
28.•
Zurück zum Zitat Tanis W, Scholtens A, Habets J, et al. Fusion of Cardiac Computed Tomography Angiography and 18 F-Fluorodesoxyglucose Positron Emission Tomography for the Detection of Prosthetic Heart Valve Endocarditis. J Am Coll Cardiol Imaging. 2013. doi:10.1016/j.jcmg.2013.07.004. This was an “iPix-Imaging Vignette” in the journal with typical images showing that FDG PET/CT could provide unique and incremental information over echocardiography and CTA in diagnosing prosthesis valve endocarditis and its complication of peri-annular abscess. Meanwhile, FDG PET/CT could confirm the diagnosis of infection by echocardiography and CTA, but provide additional information of extra-cardiac infection sites. Tanis W, Scholtens A, Habets J, et al. Fusion of Cardiac Computed Tomography Angiography and 18 F-Fluorodesoxyglucose Positron Emission Tomography for the Detection of Prosthetic Heart Valve Endocarditis. J Am Coll Cardiol Imaging. 2013. doi:10.​1016/​j.​jcmg.​2013.​07.​004. This was an “iPix-Imaging Vignette” in the journal with typical images showing that FDG PET/CT could provide unique and incremental information over echocardiography and CTA in diagnosing prosthesis valve endocarditis and its complication of peri-annular abscess. Meanwhile, FDG PET/CT could confirm the diagnosis of infection by echocardiography and CTA, but provide additional information of extra-cardiac infection sites.
29.
Zurück zum Zitat Dilsizian V, Achenbach S, Narula J. On Adding Versus Selecting Imaging Modalities for Incremental Diagnosis: A Case-Study of 18 F-Fluorodeoxyglucose PET/CT in Prosthetic Valve Endocarditis. Imaging: J Am Coll Cardiol; 2013. doi:10.1016/j.jcmg.2013.07.005. Dilsizian V, Achenbach S, Narula J. On Adding Versus Selecting Imaging Modalities for Incremental Diagnosis: A Case-Study of 18 F-Fluorodeoxyglucose PET/CT in Prosthetic Valve Endocarditis. Imaging: J Am Coll Cardiol; 2013. doi:10.​1016/​j.​jcmg.​2013.​07.​005.
Metadaten
Titel
The Potential of FDG PET/CT for Early Diagnosis of Cardiac Device and Prosthetic Valve Infection Before Morphologic Damages Ensue
verfasst von
Wengen Chen
Jongho Kim
Olga P. Molchanova-Cook
Vasken Dilsizian
Publikationsdatum
01.03.2014
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 3/2014
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-013-0459-y

Weitere Artikel der Ausgabe 3/2014

Current Cardiology Reports 3/2014 Zur Ausgabe

Ischemic Heart Disease (D Mukherjee, Section Editor)

Off-Pump Versus On-Pump Coronary Artery Bypass Grafting

Peripheral Vascular Disease (MH Shishehbor, Section Editor)

Current State of Anticoagulants to Treat Deep Venous Thrombosis

Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitus in Morbidly Obese Patients

Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Statin Treatment, New-Onset Diabetes, and Other Adverse Effects: A Systematic Review

Peripheral Vascular Disease (MH Shishehbor, Section Editor)

Management of Symptomatic Carotid Disease in 2014

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.